FDA Inspection 1092741 — General Clinical Imaging Services
The FDA completed an inspection of General Clinical Imaging Services on May 10, 2019 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berlin (Germany)
Additional Details
Sponsor, Contract Research Organization